Chugai Pharmaceutical Co., Ltd. (4519)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Chugai Pharmaceutical Co., Ltd. (4519)
Go deeper and ask any question about 4519
Company Performance
Current Price
as of Sep 17, 2024$48.84
P/E Ratio
31.82
Market Cap
$79.62B
Description
Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.
Metrics
Overview
- HQTokyo, TY
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- Ticker4519
- Price$48.844509+2.28%
Trading Information
- Market Cap$79.62B
- Float37.19%
- Average Daily Volume (1m)2,296,990
- Average Daily Volume (3m)2,712,129
- EPS$215.78
Company
- Revenue$1.08T
- Rev Growth (1yr)18.13%
- Net Income$111.86B
- Gross Margin72.16%
- EBITDA Margin50.68%
- EBITDA$160.12B
- EV$8.60T
- EV/Revenue7.93
- P/E31.82
- P/S10.42
Documents
Factset Street Account
Factset